FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897286847> ?p ?o ?g. }

• W2897286847 endingPage "3644" @default.
• W2897286847 startingPage "3626" @default.
• W2897286847 abstract "Abstract Acute heart failure (HF) and in particular, cardiogenic shock are associated with high morbidity and mortality. A therapeutic dilemma is that the use of positive inotropic agents, such as catecholamines or phosphodiesterase-inhibitors, is associated with increased mortality. Newer drugs, such as levosimendan or omecamtiv mecarbil, target sarcomeres to improve systolic function putatively without elevating intracellular Ca2+. Although meta-analyses of smaller trials suggested that levosimendan is associated with a better outcome than dobutamine, larger comparative trials failed to confirm this observation. For omecamtiv mecarbil, Phase II clinical trials suggest a favourable haemodynamic profile in patients with acute and chronic HF, and a Phase III morbidity/mortality trial in patients with chronic HF has recently begun. Here, we review the pathophysiological basis of systolic dysfunction in patients with HF and the mechanisms through which different inotropic agents improve cardiac function. Since adenosine triphosphate and reactive oxygen species production in mitochondria are intimately linked to the processes of excitation–contraction coupling, we also discuss the impact of inotropic agents on mitochondrial bioenergetics and redox regulation. Therefore, this position paper should help identify novel targets for treatments that could not only safely improve systolic and diastolic function acutely, but potentially also myocardial structure and function over a longer-term." @default.
• W2897286847 created "2018-10-26" @default.
• W2897286847 creator A5002233320 @default.
• W2897286847 creator A5009905903 @default.
• W2897286847 creator A5011450375 @default.
• W2897286847 creator A5013727186 @default.
• W2897286847 creator A5016118935 @default.
• W2897286847 creator A5017160240 @default.
• W2897286847 creator A5017935429 @default.
• W2897286847 creator A5026005110 @default.
• W2897286847 creator A5031658795 @default.
• W2897286847 creator A5032263710 @default.
• W2897286847 creator A5035642806 @default.
• W2897286847 creator A5043563400 @default.
• W2897286847 creator A5044635006 @default.
• W2897286847 creator A5045778168 @default.
• W2897286847 creator A5048507046 @default.
• W2897286847 creator A5049562211 @default.
• W2897286847 creator A5053760015 @default.
• W2897286847 creator A5054496507 @default.
• W2897286847 creator A5054708047 @default.
• W2897286847 creator A5058733310 @default.
• W2897286847 creator A5058830049 @default.
• W2897286847 creator A5061316252 @default.
• W2897286847 creator A5063519328 @default.
• W2897286847 creator A5065724319 @default.
• W2897286847 creator A5066275468 @default.
• W2897286847 creator A5066349732 @default.
• W2897286847 creator A5067224727 @default.
• W2897286847 creator A5067972379 @default.
• W2897286847 creator A5068650860 @default.
• W2897286847 creator A5070351037 @default.
• W2897286847 creator A5076848838 @default.
• W2897286847 creator A5077082143 @default.
• W2897286847 creator A5079600079 @default.
• W2897286847 creator A5079763125 @default.
• W2897286847 creator A5083445823 @default.
• W2897286847 creator A5083732647 @default.
• W2897286847 creator A5085949307 @default.
• W2897286847 creator A5088969624 @default.
• W2897286847 creator A5091663935 @default.
• W2897286847 date "2018-10-08" @default.
• W2897286847 modified "2023-10-17" @default.
• W2897286847 title "Treatments targeting inotropy" @default.
• W2897286847 cites W1488020481 @default.
• W2897286847 cites W1545935022 @default.
• W2897286847 cites W1556535974 @default.
• W2897286847 cites W1571718974 @default.
• W2897286847 cites W1764072566 @default.
• W2897286847 cites W1822797420 @default.
• W2897286847 cites W1867945077 @default.
• W2897286847 cites W1910071664 @default.
• W2897286847 cites W1925950021 @default.
• W2897286847 cites W1967428301 @default.
• W2897286847 cites W1967677604 @default.
• W2897286847 cites W1968925070 @default.
• W2897286847 cites W1978063892 @default.
• W2897286847 cites W1979622294 @default.
• W2897286847 cites W1979697035 @default.
• W2897286847 cites W1984848816 @default.
• W2897286847 cites W1985928412 @default.
• W2897286847 cites W1991814810 @default.
• W2897286847 cites W2002946832 @default.
• W2897286847 cites W2002958873 @default.
• W2897286847 cites W2007011272 @default.
• W2897286847 cites W2010094172 @default.
• W2897286847 cites W2011160790 @default.
• W2897286847 cites W2016646689 @default.
• W2897286847 cites W2017397568 @default.
• W2897286847 cites W2020954602 @default.
• W2897286847 cites W2023005794 @default.
• W2897286847 cites W2025620168 @default.
• W2897286847 cites W2030248934 @default.
• W2897286847 cites W2030583987 @default.
• W2897286847 cites W2033427134 @default.
• W2897286847 cites W2033845686 @default.
• W2897286847 cites W2034592170 @default.
• W2897286847 cites W2037397160 @default.
• W2897286847 cites W2041543580 @default.
• W2897286847 cites W2044110796 @default.
• W2897286847 cites W2049658384 @default.
• W2897286847 cites W2052552544 @default.
• W2897286847 cites W2056840703 @default.
• W2897286847 cites W2057736164 @default.
• W2897286847 cites W2058542276 @default.
• W2897286847 cites W2058581105 @default.
• W2897286847 cites W2060453674 @default.
• W2897286847 cites W2064363834 @default.
• W2897286847 cites W2065281025 @default.
• W2897286847 cites W2067839119 @default.
• W2897286847 cites W2077146886 @default.
• W2897286847 cites W2078748771 @default.
• W2897286847 cites W2082879125 @default.
• W2897286847 cites W2085167361 @default.
• W2897286847 cites W2088749722 @default.
• W2897286847 cites W2094829742 @default.
• W2897286847 cites W2096345172 @default.
• W2897286847 cites W2098089737 @default.

• next